1Ngai SW, Tang OS, Ho PC. Randomized comparison of vaginal (200 microg every 3h) and oral (400 microg every 3h) misoprostol when combined with mifepristone in termination of second trimester pregnancy. Hum Reprod, 2000, 15(10): 2205-2208
2le-Roux PA, Pahal GS, Hoffman L, et al. Second trimester termination of pregnancy for fetal anomaly or death: comparing mifepristone/misoprostol to gemeprost. Eur J Obstet Gynecol Reprod Biol, 2001, 95(1): 52-54
3Daisley H Jr. Maternal mortality following the use of misoprostol. Med Sci Law, 2000, 40(1): 78-82
4Bartley J, Tong S, Everington D, et al. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost. Contraception, 2000, 62(6): 297-303
5Rabe T, Basse H, Thuro H, et al. Effect of the PGE1 methyl analog misoprostol on the pregnant uterus in the first trimesiter. Geburttshilfe Frauenheilkd, 1987, 47(5): 324-331
6Bugalho A, Bique C, Almeida L, et al. The effectiveness of intravaginal misoprostol (Cytotec) in inducing abortion after eleven weeks of pregnancy. Stud Fam Plann, 1993, 24(5): 319-323
7Bugalho A, Bique C, Pereira C, et al. Uterine evacuation by vaginal misoprostol after second trimester pregnancy interruption. Acta Obstet Gynecol Scand, 1996, 75(3): 270-273
8Rae DW, Smith FW, Templeton AA. Magnetic resonance imaging of the human cervix: a study of the effects of prostaglandins in the first trimester. Hum Reprod, 2001, 16(8): 1744-1747
9Bugalho A, Faundes A, Jamisse L. et al. Evaluation of the effectiveness of vaginal misoprostol to induce first trimester abortion. Contraception, 1996, 53(4): 244-246
10Carbonell JL, Varela L, Velazco A, et al. The use of misoprostol for abortion at ＜or=9 weeks' gestation. Eur J Contracept Reprod Health Care, 1997, 2(3): 181-185
